Curran Simpson - Chief Oper. & Tech. Officer, Regenxbio Inc

As of January 4, 2022


Curran Simpson Net Worth

  • Net worth is estimated to be at least $17.43M
  • Owns at least 17,748 units of Regenxbio Inc stock
  • Sold an estimated value of $16.9M in the last 7 years at Regenxbio Inc

Curran Simpson Compensation at Regenxbio Inc in 2020

  • Earned a $428,152 salary
  • Received a total compensation of $1,750,865

Curran Simpson Trading

  • Largest purchase of shares was 62,309 units , worth over $1.31M on October 18, 2018
  • Largest sale of shares was 62,309 units , worth over $3.79M on October 18, 2018
  • In total has made about 25 transactions over 7 years
  • Usually trades in January, with the busiest year in 2019 and 2017
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Curran Simpson Mailing Address

  • Mailing address is C/o Regenxbio Inc. 9600 Blackwell Road, Suite 210 Rockville MD 20850 MD

Regenxbio Inc Executive Compensation

Name
Year
Salary
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Total
Kenneth T. Mills 2020 $613,403 $16,388 $16,388 $16,388 $7,644,087
Kenneth T. Mills 2019 $595,537 $16,100 $16,100 $16,100 $6,147,269
Kenneth T. Mills 2018 $546,364 $15,813 $15,813 $15,813 $4,938,199
Vit Vasista 2020 $453,188 $16,388 $16,388 $16,388 $1,881,639
Vit Vasista 2019 $439,988 $16,100 $16,100 $16,100 $2,184,616
Vit Vasista 2018 $379,300 $15,813 $15,813 $15,813 $1,944,391
Curran Simpson 2020 $428,152 $16,388 $16,388 $16,388 $1,750,865
Curran Simpson 2019 $382,439 $16,100 $16,100 $16,100 $1,825,744
Curran Simpson 2018 $371,300 $14,844 $14,844 $14,844 $1,901,142
Olivier Danos, Ph.D. 2020 $433,908 $16,388 $16,388 $16,388 $1,805,415
Olivier Danos, Ph.D. 2019 $421,270 $16,100 $16,100 $16,100 $1,926,420
Olivier Danos, Ph.D. 2018 $409,000 $14,462 $14,462 $14,462 $1,613,769
Patrick J. Christmas 2020 $426,252 $16,388 $16,388 $16,388 $1,843,929
Patrick J. Christmas 2019 $405,954 $16,100 $16,100 $16,100 $1,833,033
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1590877/000156459021019415/rgnx-def14a_20210604.htm

Regenxbio Inc Insider Trading

  • The most recent transaction was 2,750 units sold on January 4, 2022 by Steve Pakola worth over $91.6K
  • In the last 7 years, insiders at Regenxbio Inc sold an estimated value of $96.3M and bought an estimated value of $16.87M
  • The most active traders are Kenneth Mills, President and CEO,  Vittal Vasista, Chief Financial Officer,  and Curran Simpson, Chief Oper. & Tech. Officer
  • Insider trading is most common in January, with the busiest year in 2018
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1